For Immediate Release
Erik Swenson Named Incoming Editor-in-Chief of High Altitude Medicine & Biology
Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com
New Rochelle, NY, June 26, 2015—John B. West, MD, PhD has provided extraordinary leadership for High Altitude Medicine & Biology over the last 16 years since its launch in 2000. Launching a brand-new specialty journal and making it the leading forum in its field is no small feat, and Dr. West did this admirably. Dr. West will be stepping down from his role and will remain as Founding Editor.
Mary Ann Liebert, Inc., publishers are pleased to announce that Erik R. Swenson, MD will assume the role of Editor-in-Chief of the journal in 2016. Dr. Swenson is Professor of Medicine, Physiology, and Biophysics at the University of Washington in Seattle, WA. He graduated from Princeton University in 1974 and received his MD from University of California, San Diego in 1979, where he first met John West. He did his medical residency at the University of Pennsylvania followed by fellowships in pulmonary and critical care medicine at the Royal Postgraduate Medical School in London and the University of Washington, where he joined the faculty in 1985 and continues to care for patients, teach, and maintain his research activities at the Veterans Affairs Medical Center.
Dr. Swenson’s work over the past 20 years has been supported continuously by grants from the NIH, Veterans Administration, and American Lung Association. He serves as an advisor to the U.S. Food and Drug Administration, Department of Veterans Affairs, National Institutes of Health, and American Lung Association. He serves on the editorial boards of the Journal of Applied Physiology and American Journal of Respiratory and Critical Care Medicine. Dr. Swenson has had a long abiding interest in high altitude physiology and medicine with over 90 articles in the field spanning work done in cells up to animals (aquatic and terrestrial) and humans under hypoxic conditions. This work has included studies on Mt. McKinley in Alaska, the Himalayas, the Andes, and the Alps in healthy people and in those with various high altitude illnesses, particularly high altitude pulmonary edema. Much of his work has focused on the lungs, kidneys, and brain with a special interest in carbonic anhydrase and its inhibitors in preventing and treating high altitude illnesses.
We look forward to the strong continuing commitment of our editorial board, reviewers, and authors.
About the Journal
High Altitude Medicine & Biology is a peer-reviewed journal focused exclusively on the latest advances in high altitude life sciences, and is the primary source of information for clinicians, physiologists, and researchers studying the effects of reduced atmospheric pressure and oxygen deprivation. The Journal delivers critical findings on the impact of high altitude on lung and heart disease, appetite and weight loss, pulmonary and cerebral edema, hypertension, dehydration, infertility, and other diseases. It covers the full spectrum of high altitude life sciences from pathology to human and animal ecology.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including Tissue Engineering, and Stem Cells and Development, and Journal of Aerosol and Pulmonary Drug Delivery. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s more than 80 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers website.